Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.

A series of urea-based N-1-(2-aminoethyl)-indazoles was synthesized and evaluated for melanin-concentrating hormone receptor 1 (MCHr1) antagonism in both binding and functional assays. Several compounds that acted as MCHr1 antagonists were identified, and optimization afforded a compound with excellent binding affinity, good functional potency, and oral efficacy in a chronic model for weight loss in diet-induced obese mice.

[1]  O. Civelli,et al.  Melanin-concentrating Hormone Receptor: An Orphan Receptor Fits the Key , 2000, Trends in Endocrinology & Metabolism.

[2]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[3]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[4]  M. Schwartz,et al.  Rats lighten up with MCH antagonist , 2002, Nature Medicine.

[5]  K. Sjögren,et al.  Body fat content can be predicted in vivo in mice using a modified dual-energy X-ray absorptiometry technique. , 2001, The Journal of nutrition.

[6]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Bickerdike.  5-HT2C receptor agonists as potential drugs for the treatment of obesity. , 2003, Current topics in medicinal chemistry.

[8]  H. Hsiung,et al.  Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. , 2002, Endocrinology.

[9]  Mark D. McBriar,et al.  Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity , 2004, Expert opinion on investigational drugs.

[10]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[11]  Yuji Ishihara,et al.  T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. , 2002, European journal of pharmacology.

[12]  Andrew Browning,et al.  Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents , 2004 .